Related Content 1
What we do with your data
Global Drug Survey values its independence from political, government and lobbying groups. We respect the right of individuals to use substances as a source of intoxication and pleasure. We are interested in promoting health and reducing harm for individuals and communities and believe the provision of transparent, objective, real time data is good for everyone. Our data is used to produce reports that allow our findings to be widely distributed to those interested in the areas that we cover. Our data is compiled and packaged in different ways to address the needs of the various audiences that we wish to engage with.
The first report
We provide a summary data report to our media partners that represents a preliminary analyses of the data extracted from the surveys that were completed. This is usually provided one month after data collection has stopped and allows dissemination of early findings to the wider public usually within 3-4 months of the survey commencing.
We often present our findings at scientific / academic conferences as well as at expert advisory committees that address issues of health and drug policy. Although these may be government-funded organisations, the focus of our work and the results that we choose to present remain fully at the discretion of Global Drug Survey. We often post these presentations on this site.
We also collaborate with academic partners to produce scientific papers, which are referenced throughout the site.
We may also produce specific reports for public health organisations to address a particular health issue (e.g the effects of synthetic cannabinoids versus those of natural cannabis, or the aetiology and progression of k-cramps). We may be paid for these reports and provide them with the understanding that they will be used to inform the development of local service delivery.
We may also prepare reports for international monitoring and health agencies such as the World Health Organisation (WHO) or the European Centre for the Monitoring of Dependence on Drugs and Alcohol (EMCDDA). In some instances, we may provide more local reports on drug trends to inform local health policy development.
If you have expressed an interest in participating in other research by providing your contact details, we may pass on your contact details to academic collaborators but only after they have received ethical approval from their university ethics committee. We will never share your original drug use data with these groups, though we may indicate that you have reported use of a particular drug in the last 12 months.
What we do not do
We never share our raw data with any other organisation
We never sell your personal data
We never provide reports to law enforcement agencies
All GDS data remains anonymous